C.R.S. Section 25-45-106
Access to investigational drugs, biological products, and devices

25‑45‑101
Short title 25‑45‑102
Legislative declaration 25‑45‑103
Definitions 25‑45‑104
Drug manufacturers - availability of investigational drugs, biological products, or devices - costs - insurance coverage 25‑45‑105
Action against health-care provider’s license or medicare certification prohibited 25‑45‑106
Access to investigational drugs, biological products, and devices 25‑45‑107
No cause of action created 25‑45‑108
Effect on health-care coverage